Gene · 7399
Papers2,630
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
841 to 860 of 2,630
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The LORF5 Gene Is Non-essential for Replication but Important for Duck Plague Virus Cell-to-Cell Spread Efficiently in Host Cells. | Front Microbiol | 2021 | 34925260 | PubTator, text mining | PubMed |
| Prime Editing for Inherited Retinal Diseases. | Front Genome Ed | 2021 | 34901928 | PubTator, text mining | PubMed |
| Identification of CCL4 as an Immune-Related Prognostic Biomarker Associated With Tumor Proliferation and the Tumor Microenvironment in Clear Cell Renal Cell Carcinoma. | Front Oncol | 2021 | 34900664 | PubTator, text mining | PubMed |
| Bioinformatic Analysis of Immune Significance of RYR2 Mutation in Breast Cancer. | Biomed Res Int | 2021 | 34888385 | PubTator, text mining | PubMed |
| Identification of Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma. | Front Immunol | 2021 | 34887858 | PubTator, text mining | PubMed |
| Identification of ACOT13 and PTGER2 as novel candidate genes of autosomal dominant polycystic kidney disease through whole exome sequencing. | Eur J Med Res | 2021 | 34886911 | PubTator, text mining | PubMed |
| Genetic and immunologic features of recurrent stage I lung adenocarcinoma. | Sci Rep | 2021 | 34880292 | PubTator, text mining | PubMed |
| Potential Clinical Value of 5-Hydroxytryptamine Receptor 3C as a Prognostic Biomarker for Lung Cancer. | J Oncol | 2021 | 34868311 | PubTator, text mining | PubMed |
| Editorial: Advances in Cell and Gene Therapy in Treating Neural Diseases. | Front Cell Neurosci | 2021 | 34867209 | PubTator, text mining | PubMed |
| CSMD1 Mutation Related to Immunity Can Be Used as a Marker to Evaluate the Clinical Therapeutic Effect and Prognosis of Patients with Esophageal Cancer. | Int J Gen Med | 2021 | 34849012 | PubTator, text mining | PubMed |
| Prognostic and Immunological Significance of CXCR2 in Ovarian Cancer: A Promising Target for Survival Outcome and Immunotherapeutic Response Assessment. | Dis Markers | 2021 | 34840630 | PubTator, text mining | PubMed |
| High-resolution mapping and digital atlas of subcortical regions in the macaque monkey based on matched MAP-MRI and histology. | Neuroimage | 2021 | 34838750 | PubTator, text mining | PubMed |
| The New Kid on the Block: HLA-C, a Key Regulator of Natural Killer Cells in Viral Immunity. | Cells | 2021 | 34831331 | PubTator, text mining | PubMed |
| DNA Methylation Signature in Mononuclear Cells and Proinflammatory Cytokines May Define Molecular Subtypes in Sporadic Meniere Disease. | Biomedicines | 2021 | 34829759 | PubTator, text mining | PubMed |
| The Genetic Landscape of Inherited Retinal Diseases in a Mexican Cohort: Genes, Mutations and Phenotypes. | Genes (Basel) | 2021 | 34828430 | PubTator, text mining | PubMed |
| Recent Development of Ruminant Vaccine Against Viral Diseases. | Front Vet Sci | 2021 | 34805327 | PubTator, text mining | PubMed |
| Multi-Omics Analysis of the Effects of Smoking on Human Tumors. | Front Mol Biosci | 2021 | 34796198 | PubTator, text mining | PubMed |
| USH2A Mutation is Associated With Tumor Mutation Burden and Antitumor Immunity in Patients With Colon Adenocarcinoma. | Front Genet | 2021 | 34795697 | PubTator, text mining | PubMed |
| Whole genome sequencing and in vitro splice assays reveal genetic causes for inherited retinal diseases. | NPJ Genom Med | 2021 | 34795310 | PubTator, text mining | PubMed |
| Progress in Gene Editing Tools and Their Potential for Correcting Mutations Underlying Hearing and Vision Loss. | Front Genome Ed | 2021 | 34778871 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7399/papers?page=43